We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Shire Prevails In Patent Trial Over Mylan's Generic Lialda

Law360, New York (January 27, 2017, 8:45 PM EST) -- Following a four-day bench trial held in September, a Florida federal judge concluded on Friday that Mylan Pharmaceuticals Inc.'s proposed generic version of Shire Development LLC's bowel disease drug Lialda infringes...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.